Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
74 studies found for:    "Wegeners granulomatosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Wegeners granulomatosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Etanercept for Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Etanercept
2 Terminated Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis
Condition: Wegeners Granulomatosis
Interventions: Drug: Gusperimus + glucocorticoids;   Drug: cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids
3 Completed Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Gusperimus
4 Completed Daclizumab to Treat Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Daclizumab
5 Completed
Has Results
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Abatacept
6 Completed An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
Condition: Wegener's Granulomatosis
Intervention: Drug: Rituximab
7 Completed Study of One Protein Implicated in Wegener Disease
Condition: Wegener's Granulomatosis
Intervention: Biological: Physiopathology Endpoint Classification
8 Completed Treatment of Wegener's Granulomatosis With Cyclophosphamide
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: cyclophosphamide
9 Completed Etanercept to Treat Wegener's Granulomatosis
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: Etanercept
10 Completed Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: Mycophenolate Mofetil
11 Completed Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: Interleukin-10
12 Completed Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention: Drug: Mycophenolate Mofetil
13 Recruiting Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
Condition: Granulomatosis With Polyangiitis
Interventions: Other: Blood samples and clinical data;   Other: Blood sample
14 Not yet recruiting Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Condition: Granulomatosis With Polyangiitis (Wegener's Granulomatosis)
Interventions: Drug: Rituximab;   Other: Placebo
15 Completed Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
Conditions: Inflammation;   Vasculitis;   Wegener's Granulomatosis
Intervention:
16 Recruiting A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
Condition: Wegener's Granulomatosis or Microscopic Polyangiitis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone;   Drug: Rituximab
17 Not yet recruiting Rituximab in Eosinophilic Granulomatosis With Polyangiitis
Condition: Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Interventions: Drug: Rituximab;   Drug: Placebo-rituximab;   Drug: Cyclophosphamide;   Drug: Placebo-cyclophosphamide
18 Recruiting A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Granulomatosis With Polyangiitis
Intervention: Drug: Rituximab
19 Completed Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
Conditions: Vasculitis;   Wegener's Granulomatosis
Intervention:
20 Active, not recruiting
Has Results
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Intervention: Drug: Rituximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.